News
- Author:
- Andrew D. Bowser
Publish date: June 6, 2019
CHICAGO – However, modest benefit and moderate toxicity suggest need for new treatments, especially targeted ones.
News
- Author:
- Andrew D. Bowser
Publish date: June 5, 2019
CHICAGO – Significant efficacy results need to be viewed in light of increased toxicity.
News
- Author:
- Andrew D. Bowser
Publish date: June 5, 2019
CHICAGO – Gemcitabine plus nab-paclitaxel did not extend disease-free survival versus gemcitabine alone in a phase 3 study, but overall survival da...
News
- Author:
- Andrew D. Bowser
Publish date: June 5, 2019
CHICAGO – CARMENA update confirms cytoreductive nephrectomy should not be standard of care for most cases of metastatic renal cell carcinoma.
Video
- Author:
- Andrew D. Bowser
Publish date: June 3, 2019
CHICAGO – More centers should develop expertise in laparoscopic approach, investigator says.
News
- Author:
- Andrew D. Bowser
Publish date: June 3, 2019
CHICAGO – Magnitude of clinical benefit nevertheless on par with previous study findings, according to investigator.
News
- Author:
- Andrew D. Bowser
Publish date: June 3, 2019
New IDEA group study comes to finding similar to that in low-risk stage III disease.
News
- Author:
- Andrew D. Bowser
Publish date: June 2, 2019
CHICAGO – PARP inhibitor after chemotherapy extended progression-free survival in patients with metastatic disease an...
News
- Author:
- Andrew D. Bowser
Publish date: June 1, 2019
CHICAGO – Pembrolizumab is now at least an alternative to chemotherapy, if not preferred, in many of these patients, ...
News
- Author:
- Andrew D. Bowser
Publish date: June 1, 2019
CHICAGO – Two antibody approaches showed promising preliminary activity and manageable safety, in studies designed to address the need for new...
News
- Author:
- Andrew D. Bowser
Publish date: May 20, 2019
Women with psoriatic arthritis and ankylosing spondylitis generally have favorable pregnancy outcomes, but high disease activity during pregnancy c...
News
- Author:
- Andrew D. Bowser
Publish date: May 18, 2019
Of six fatal pulmonary hemorrhages, four occurred in patients receiving bevacizumab or pazopanib within 30 days of stereotactic body radiation ther...
News
- Author:
- Andrew D. Bowser
Publish date: May 18, 2019
Supraomohyoid neck dissection is likely adequate for the subset of patients with oral cancer and node-negative disease.
News
- Author:
- Andrew D. Bowser
Publish date: May 17, 2019
Public policies that consider socioeconomic and health-related disparities in isolation may miss the big picture.
News
- Author:
- Andrew D. Bowser
Publish date: May 17, 2019
One common EGFR tyrosine kinase inhibitor–sensitizing allele may be associated with similar benefit versus EGFR wild-type lung tumors, analysis sug...
